There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Data availability:

Comments

Comment on this article

Cited by 3

KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m6A-dependent manner
Authors: Xi Lin, Rongyi Ye, Zhiming Li …
Drug delivery systems of gefitinib for improved cancer therapy: A review
Authors: Deepak Nagdiya, Manish Kumar, Sanchit Arora …
Gefitinib improves severe bronchorrhea and prolongs the survival of a patient with lung invasive mucinous adenocarcinoma: A case report
Authors: Guo-Chun Ou, Wen Luo, Wei-Shan Zhang …

See all cited by

Gefitinib: An Updated Review of its Role in the Cancer Management, its Nanotechnological Interventions, Recent Patents and Clinical Trials

Read this article at

Related collections

Management Information Systems

Comments

Comment on this article

Similar content 2,365

Cited by 3